These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 19445166)
1. [Interaction between Actinobacillus pleuropneumoniae RTX toxin and host--a review]. Fan S; Liu H; Chen Y; Chen H; He Q Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):141-6. PubMed ID: 19445166 [TBL] [Abstract][Full Text] [Related]
2. In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae. Liu J; Chen X; Tan C; Guo Y; Chen Y; Fu S; Bei W; Chen H Vet Microbiol; 2009 Jun; 137(3-4):282-9. PubMed ID: 19251385 [TBL] [Abstract][Full Text] [Related]
3. Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae. Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Rodríguez-Ferri EF Microbiologia; 1996 Jun; 12(2):171-84. PubMed ID: 8767702 [TBL] [Abstract][Full Text] [Related]
4. Concurrent host-pathogen gene expression in the lungs of pigs challenged with Actinobacillus pleuropneumoniae. Brogaard L; Klitgaard K; Heegaard PM; Hansen MS; Jensen TK; Skovgaard K BMC Genomics; 2015 May; 16(1):417. PubMed ID: 26018580 [TBL] [Abstract][Full Text] [Related]
5. Mutation in the LPS outer core biosynthesis gene, galU, affects LPS interaction with the RTX toxins ApxI and ApxII and cytolytic activity of Actinobacillus pleuropneumoniae serotype 1. Ramjeet M; Cox AD; Hancock MA; Mourez M; Labrie J; Gottschalk M; Jacques M Mol Microbiol; 2008 Oct; 70(1):221-35. PubMed ID: 18713318 [TBL] [Abstract][Full Text] [Related]
6. Use of recombinant ApxIV in serodiagnosis of Actinobacillus pleuropneumoniae infections, development and prevalidation of the ApxIV ELISA. Dreyfus A; Schaller A; Nivollet S; Segers RP; Kobisch M; Mieli L; Soerensen V; Hüssy D; Miserez R; Zimmermann W; Inderbitzin F; Frey J Vet Microbiol; 2004 Apr; 99(3-4):227-38. PubMed ID: 15066725 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice. Shao M; Wang Y; Wang C; Guo Y; Peng Y; Liu J; Li G; Liu H; Liu S Acta Vet Scand; 2010 Sep; 52(1):52. PubMed ID: 20831818 [TBL] [Abstract][Full Text] [Related]
8. Surface polysaccharides and iron-uptake systems of Actinobacillus pleuropneumoniae. Jacques M Can J Vet Res; 2004 Apr; 68(2):81-5. PubMed ID: 15188950 [TBL] [Abstract][Full Text] [Related]
9. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection. Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123 [TBL] [Abstract][Full Text] [Related]
10. Transcript profiling of the immunological interactions between Actinobacillus pleuropneumoniae serotype 7 and the host by dual RNA-seq. Li P; Xu Z; Sun X; Yin Y; Fan Y; Zhao J; Mao X; Huang J; Yang F; Zhu L BMC Microbiol; 2017 Sep; 17(1):193. PubMed ID: 28899359 [TBL] [Abstract][Full Text] [Related]
12. An Actinobacillus pleuropneumoniae arcA deletion mutant is attenuated and deficient in biofilm formation. Buettner FF; Maas A; Gerlach GF Vet Microbiol; 2008 Feb; 127(1-2):106-15. PubMed ID: 17881160 [TBL] [Abstract][Full Text] [Related]
13. [Study of the virulence of Actinobacillus pleuropneumoniae in finishing pigs as a basis for vaccination development]. Hennig-Pauka I; Baltes N; Jacobsen I; Stratmann-Selke J; Gerlach GF; Selbitz HJ; Waldmann KH Berl Munch Tierarztl Wochenschr; 2008; 121(5-6):189-97. PubMed ID: 18557522 [TBL] [Abstract][Full Text] [Related]
14. Actinobacillus pleuropneumoniae: virulence and gene cloning. Negrete-Abascal E; Tenorio V; García C; Godínez D; Serrano JJ; de la Cuadra JA; de la Garza MA Arch Med Res; 1994; 25(2):229-33. PubMed ID: 7919819 [TBL] [Abstract][Full Text] [Related]
15. Characterization and immunogenicity of an apxIA mutant of Actinobacillus pleuropneumoniae. Xu F; Chen X; Shi A; Yang B; Wang J; Li Y; Guo X; Blackall PJ; Yang H Vet Microbiol; 2006 Dec; 118(3-4):230-9. PubMed ID: 16930871 [TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines. Passmore IJ; Andrejeva A; Wren BW; Cuccui J BMC Vet Res; 2019 Jan; 15(1):6. PubMed ID: 30606265 [TBL] [Abstract][Full Text] [Related]
17. Risk assessment of transmission of capsule-deficient, recombinant Actinobacillus pleuropneumoniae. Inzana TJ; Glindemann G; Fenwick B; Longstreth J; Ward D Vet Microbiol; 2004 Nov; 104(1-2):63-71. PubMed ID: 15530740 [TBL] [Abstract][Full Text] [Related]
18. Both ApxI and ApxII of Actinobacillus pleuropneumoniae serotype 1 are necessary for full virulence. Boekema BK; Kamp EM; Smits MA; Smith HE; Stockhofe-Zurwieden N Vet Microbiol; 2004 May; 100(1-2):17-23. PubMed ID: 15135509 [TBL] [Abstract][Full Text] [Related]